CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed)
This grant opportunity is for developing early-stage therapeutics to counteract health problems from toxic chemical exposure, such as in terrorist attacks or industrial accidents. It covers chemical warfare agents, toxic industrial chemicals, pesticides, and certain pharmaceuticals. The grant involves two phases: the UG3 phase, which focuses on validating therapeutic targets and characterizing…
This Funding Opportunity Announcement (FOA) solicits applications for the early-stage development of therapeutics to mitigate the adverse health effects resulting from toxic chemical exposure. Chemical threats are toxic compounds that could be used in a terrorist attack or accidentally released …
Funding Source
Awards & funding
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers